<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2115">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04431414</url>
  </required_header>
  <id_info>
    <org_study_id>CoVPN 5001</org_study_id>
    <secondary_id>5UM1AI068614-14</secondary_id>
    <nct_id>NCT04431414</nct_id>
  </id_info>
  <brief_title>A Study of Immune Responses to the Virus That Causes COVID-19</brief_title>
  <acronym>CoVPN 5001</acronym>
  <official_title>A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>COVID-19 Prevention Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>COVID-19 Prevention Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn more about the acute response to infection with and
      recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
      Some people know this virus by the name &quot;coronavirus.&quot; It can cause the disease called
      COVID-19.

      The information gained from the study can be used to help develop better tests for SARS-CoV-2
      infection and COVID-19 disease and may help in developing future vaccines, other prevention
      strategies, and treatments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective study of acute immune responses to SARSCoV-2 infection.

      The study will include 3 groups, as described in the table below. Groups are defined based on
      clinical status at enrollment, but for the purposes of data analysis, participants who
      experience disease progression can contribute data to other cohorts.

      Participants will complete six visits over 28 days followed by a health contact at Month 2
      (one month after the last scheduled visit). Additional follow up visit(s) may be added over
      time in response to evolving information regarding SARS-CoV-2 infection and COVID-19.

      Study visits may include review of medical history; interviews/questionnaires; pregnancy
      tests (for participants assigned female sex at birth); blood draws; nasal swab, nasal wash,
      and saliva sample collection; and optional stool sample collection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 20, 2020</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Response rate of SARS-CoV-2-specific B cells in peripheral blood samples</measure>
    <time_frame>Measured through day 14</time_frame>
    <description>Characterized using fluorescently labeled recombinant proteins in combination with a flow cytometry phenotyping panel</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnitude of SARS-CoV-2-specific B cells in peripheral blood samples</measure>
    <time_frame>Measured through day 14</time_frame>
    <description>Characterized using fluorescently labeled recombinant proteins in combination with a flow cytometry phenotyping panel</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Phenotypic characterization of SARS-CoV-2-specific B cells in peripheral blood samples</measure>
    <time_frame>Measured through day 14</time_frame>
    <description>Characterized using fluorescently labeled recombinant proteins in combination with a flow cytometry phenotyping panel</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Response rate of SARS-CoV-2-specific antibody binding in serum samples</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Response rate of SARS-CoV-2-specific neutralizing antibodies in serum samples</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by neutralizing antibody assay (nAb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnitude of SARS-CoV-2-specific antibody binding antibodies in serum samples</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnitude of SARS-CoV-2-specific neutralizing antibodies in serum samples</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by neutralizing antibody assay (nAb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Response rate of SARS-CoV-2-specific binding antibodies in nasal wash samples</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnitude of SARS-CoV-2-specific binding antibodies in nasal wash samples</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of leukocyte populations in peripheral blood</measure>
    <time_frame>Measured through day 14</time_frame>
    <description>Measured by flow cytometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transcriptional profiles of peripheral blood leukocytes</measure>
    <time_frame>Measured through day 14</time_frame>
    <description>Measured by gene expression analysis by RNA sequencing, real-time PCR, single-cell proteogenomic profiling</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of serum cytokines and other soluble factors</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by multiplexed protein detection assays and/or enzyme-linked immunosorbent assays (ELISA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Response rate of SARS-CoV-2-specific CD4+ and CD8+ T cells</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by flow cytometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnitude of SARS-CoV-2-specific CD4+ and CD8+ T cells</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by flow cytometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional profiling, including intracellular cytokine staining, of SARS-CoV-2-specific CD4+ and CD8+ T cells</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by flow cytometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantitation of viral RNA in nasal swabs</measure>
    <time_frame>Measured through day 28</time_frame>
    <description>Measured by extraction of nucleic acid for analysis of microorganism RNA or DNA by qPCR and/or amplicon- or metagenomics-sequencing methods and subsequent gene and taxa-level bioinformatics analyses</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>SARS-CoV-2</condition>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Persons that are PCR positive for SARS-CoV-2 and are asymptomatic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Persons that are PCR positive for SARS-CoV-2 with recent onset of mild symptoms (not hospitalized)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Persons that are PCR positive for SARS-CoV-2 and are symptomatic hospitalized patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sample collection</intervention_name>
    <description>blood, nasal swab, nasal wash, and saliva
optional stool swab</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants who have tested positive for SARSCoV-2 virus by RT-PCR.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older.

          -  Test result indicating presence of SARS-CoV-2 virus. Sites must have results from
             assays that are approved as FDA-emergency use authorized or as standard-of-care by
             other applicable regional governing bodies. For timing of testing, please see group
             specific criteria below.

          -  Ability and willingness to provide informed consent.

          -  Willingness to have clinical research staff come to place of residence or hospital if
             needed.

          -  Willingness to be followed for the planned duration of the study.

          -  Assessment of understanding: volunteer demonstrates understanding of this study.

          -  Agreement to allow access to medical records.

          -  Asymptomatic participants:

               -  No current symptoms.

               -  No symptoms consistent with COVID-19 within 2 weeks prior to positive test
                  according to the clinical judgement of the investigating clinician. Symptoms
                  include, but are not limited to, fever, headache, sore throat, cough, dyspnea,
                  rhinorrhea, diarrhea, myalgias, chills, and anosmia. Please refer to
                  https://www.cdc.gov/coronavirus/2019-ncov/symptomstesting/symptoms.html for the
                  current list of symptoms consistent with COVID-19.

               -  Positive SARS-CoV-2 RNA test within six days prior to enrollment (target time) up
                  to 10 days prior to enrollment (upper allowable window).

          -  Symptomatic (non-hospitalized) participants:

               -  Onset of mild symptoms consistent with COVID-19 within 6 days prior to enrollment
                  (target time) up to 14 days prior to enrollment (upper allowable window).
                  Symptoms of COVID-19 to be determined by the clinical judgement of the
                  investigating clinician including-- but not limited to-- fever, headache, sore
                  throat, cough, dyspnea, rhinorrhea, diarrhea myalgias, chills, and anosmia.
                  Please refer to
                  https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html for the
                  current list of symptoms consistent with COVID-19.

               -  Positive SARS-CoV-2 RNA test within six days prior to enrollment (target time) up
                  to 10 days prior to enrollment (upper allowable window).

          -  Symptomatic (hospitalized) participants

               -  Participant hospitalized for COVID-19 within 3 days prior to enrollment (note:
                  there is no timeframe for either symptom onset or timing of SARSCoV-2 PCR testing
                  for hospitalized participants)

        Exclusion Criteria:

          -  Any medical, psychiatric, occupational, or other condition that, in the judgment of
             the investigator, would interfere with, or serve as a contraindication to, protocol
             adherence or a volunteer's ability to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Will Hahn</last_name>
    <role>Study Chair</role>
    <affiliation>Fred Hutch</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amy Ward</last_name>
    <role>Study Chair</role>
    <affiliation>Cape Town - Khayelitsha</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alabama CRS</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>205-934-7349</phone>
      <email>msaag@uab.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>205-9964405</phone>
      <email>fhoward@uabmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bridge HIV CRS</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>415-437-7479</phone>
      <email>susan.buchbinder@sfdph.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>415-4377436</phone>
      <email>Theresa.Wagner@sfdph.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>305-243-2399</phone>
      <email>JCastro2@med.miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coorindator</last_name>
      <phone>305-2435621</phone>
      <email>lrohn@med.miami.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Ponce de Leon Center CRS</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>404-727-1557</phone>
      <email>cdelrio@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>404-6166313</phone>
      <email>erpatri@emory.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Hope Clinic of the Emory Vaccine Center CRS</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>404-712-1434</phone>
      <email>sedupug@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>404-7121370</phone>
      <email>shashi.nagar@emory.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New Orleans Adolescent Trials Unit CRS</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>504-988-3865</phone>
      <email>sabdali@tulane.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>504-9885348</phone>
      <email>lkozina@tulane.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University CRS</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>443-287-0517</phone>
      <email>kdooley1@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coodinator</last_name>
      <phone>410-6144036</phone>
      <email>rbecke22@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital Vaccine CRS (BWH VCRS)</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>617-732-6801</phone>
      <email>lbaden@partners.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>617-5259433</phone>
      <email>jlicona@partners.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fenway Health (FH) CRS</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>617-927-6087</phone>
      <email>Kmayer@fenwayhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>617-9276021</phone>
      <email>mgelman@fenwayhealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New Jersey Medical School Clinical Research Center CRS</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>973-972-1057</phone>
      <email>swaminsh@njms.rutgers.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>973-9723729</phone>
      <email>deshierd@njms.rutgers.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Columbia P&amp;S CRS</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>212-305-7185</phone>
      <email>mes52@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>212-3422958</phone>
      <email>sp500@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New York Blood Center CRS</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>212-570-3081</phone>
      <email>htieu@nybc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>212-3880008</phone>
      <email>dlucy@nybc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Rochester Vaccines to Prevent HIV Infection CRS</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>585-275-5871</phone>
      <email>michael_keefer@urmc.rochester.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>585-2755871</phone>
      <email>catherine_bunce@urmc.rochester.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Chapel Hill CRS</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>919-843-2723</phone>
      <email>wohl@med.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coodinator</last_name>
      <phone>919-8439975</phone>
      <email>bstraub@med.unc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Case CRS</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>216-844-2507</phone>
      <email>br@clevelandactu.org</email>
    </contact>
    <contact_backup>
      <phone>216-8442546</phone>
      <email>jb@clevelandactu.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Penn Prevention CRS</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>215-746-7346</phone>
      <email>franki@pennmedicine.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>215-7463713</phone>
      <email>ddunbar@pennmedicine.upenn.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Seattle Vaccine and Prevention CRS</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>206-667-6704</phone>
      <email>jmcelrat@fhcrc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>206-6672344</phone>
      <email>dberger@fhcrc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fundacion Huesped CRS</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>54-11-49817777</phone>
      <email>pedro.cahn@huesped.org.ar</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>54-11-49817777</phone>
      <email>valeria.alvarez@huesped.org.ar</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital General de Agudos JM Ramos Mejía CRS</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>54-11-49315252</phone>
      <email>mlosso@hivramos.org.ar</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>54-911-40392060</phone>
      <email>cabela@cical.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Gaborone CRS</name>
      <address>
        <city>Gaborone</city>
        <country>Botswana</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>267-3930335</phone>
      <email>gmasheto@bhp.org.bw</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>267-3931353</phone>
      <email>tkakhu@bhp.org.bw</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>SOM Federal University Minas Gerais Brazil NICHD CRS</name>
      <address>
        <city>Belo Horizonte</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>55-31-34099822</phone>
      <email>jorgeandradepinto@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>55-31-34099111</phone>
      <email>ffaleiroferreira@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS</name>
      <address>
        <city>Rio de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>55-21-22707064</phone>
      <email>gbeatriz@ipec.fiocruz.br</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>55-21-22707064</phone>
      <email>sandra.wagner@ipec.fiocruz.br</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kisumu Crs</name>
      <address>
        <city>Kisumu</city>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>254-722772609</phone>
      <email>hkc5@cdc.gov</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>254-721410654</phone>
      <email>rabwunza@kemricdc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Malawi CRS</name>
      <address>
        <city>Lilongwe</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>265-8614587</phone>
      <email>lchinula@unclilongwe.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>265-1755056</phone>
      <email>tmakuhunga@unclilongwe.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Merida CRS</name>
      <address>
        <city>Mérida</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>52-999-2110094</phone>
      <email>ccabrera@unamis.com.mx</email>
    </contact>
    <contact_backup>
      <phone>52-999-2110094</phone>
      <email>rrivera@unamis.com.mx</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS</name>
      <address>
        <city>Maputo</city>
        <country>Mozambique</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>258-84-3012208</phone>
      <email>ilesh.jani@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>258-82-3060500</phone>
      <email>ednaviegas@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS</name>
      <address>
        <city>Bellavista</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-997570149</phone>
      <email>jsanchez@citbm.pe</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-1-4800401</phone>
      <email>frosas@citbm.pe</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Asociacion Civil Selva Amazonica (ASCA) CRS</name>
      <address>
        <city>Iquitos</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-65-236277</phone>
      <email>mcasapia@acsaperu.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-65-236277</phone>
      <email>arimachi@acsaperu.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Barranco CRS</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-1-2067800</phone>
      <email>jrlama@impactaperu.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-1-2067800</phone>
      <email>hchapa@impactaperu.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>San Miguel CRS</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-1-5621600</phone>
      <email>pgonzales@impactaperu.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-1-5521600</phone>
      <email>msabaduche@impactaperu.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Via Libre CRS</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-12-039900</phone>
      <email>rcabello@vialibre.org.pe</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-12-039900</phone>
      <email>canton@vialibre.org.pe</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Groote Schuur HIV CRS</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-21-6506958</phone>
      <email>Catherine.Orrell@hiv-research.org.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-21-6501891</phone>
      <email>Doerieyah.Reynolds@hiv-research.org.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Khayelitsha CRS / (CIDRI UCT)</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-21-4066075</phone>
      <email>graemein@mweb.co.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-21-6501938</phone>
      <email>Rt.goliath@uct.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Masiphumelele Clinical Research Site (MASI) CRS</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>+27 (0) 21 406 6966</phone>
      <email>info@hiv-research.org.za</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chatsworth CRS</name>
      <address>
        <city>Chatsworth</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-031-4014150</phone>
      <email>nitesha.jeenarain@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-031-4014150</phone>
      <email>Lakshmi.Baboolall@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Botha's Hill CRS</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-31-7771585</phone>
      <email>Jayganthie.Naidoo@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-031-7771585</phone>
      <email>Ncamsile.Sibisi@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CAPRISA eThekwini CRS</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-31-2604550</phone>
      <email>Nesri.padayatchi@caprisa.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-31-6550658</phone>
      <email>Kieara.Ramtahal@caprisa.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vulindlela CRS</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-31-2604208</phone>
      <email>Quarraisha.abdoolkarim@caprisa.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-33-2606861</phone>
      <email>Hilton.Humphries@caprisa.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ndlovu Research Centre CoVPN CRS</name>
      <address>
        <city>Elandsdoorn</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-13-9838700</phone>
      <email>tempelman@ndlovu.com</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-13-9838700</phone>
      <email>aosman@ndlovu.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Isipingo CRS</name>
      <address>
        <city>Isipingo</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-31-9027494</phone>
      <email>Dishiki.Kalonji@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-31-9027494</phone>
      <email>girisha.kistnasami@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kliptown Soweto CRS</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-11-3424075</phone>
      <email>lazaruse@phru.co.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-11-3424075</phone>
      <email>msomis@phru.co.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Soweto HVTN CRS</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-11-9899700</phone>
      <email>laherf@phru.co.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-11-9899876</phone>
      <email>masalam@phru.co.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Aurum Institute Klerksdorp CRS</name>
      <address>
        <city>Klerksdorp</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-87-1351587</phone>
      <email>cinnes@auruminstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-87-1351587</phone>
      <email>tadonis@auruminstitute.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Qhakaza Mbokodo Research Clinic CRS</name>
      <address>
        <city>Ladysmith</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-82-4588969</phone>
      <email>plkotze@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-36-6312372</phone>
      <email>michelle01qm@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MeCRU CRS</name>
      <address>
        <city>Medunsa</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-12-5215727</phone>
      <email>maphoshane.nchabeleng@smu.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-73-9261879</phone>
      <email>innocentia.matjila@smu.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Nelson Mandela Academic Research Unit CRS</name>
      <address>
        <city>Mthatha</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-083-518407</phone>
      <email>cyasom@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-04-71500012</phone>
      <email>btutshana@witshealth.co.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rustenburg CRS</name>
      <address>
        <city>Rustenburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-87-135157</phone>
      <email>wbrumskine@auruminstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-87-1351587</phone>
      <email>tadonis@auruminstitute.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Setshaba Research Centre CRS</name>
      <address>
        <city>Soshanguve</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-12-7992422</phone>
      <email>kahmed@setshaba.org.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-12-7992422</phone>
      <email>KMapetla@setshaba.org.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tembisa Clinic 4 CoVPN CRS</name>
      <address>
        <city>Tembisa</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-82-5744541</phone>
      <email>kmngadi@auruminstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-84-4990663</phone>
      <email>yajna@auruminstitute.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tongaat CRS</name>
      <address>
        <city>Tongaat</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-032-9442208</phone>
      <email>Jayganthie.Naidoo@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-032-9442208</phone>
      <email>Thembisa.Makowa@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Verulam CRS</name>
      <address>
        <city>Verulam</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-32-5334145</phone>
      <email>Zakir.gaffoor@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-32-5334145</phone>
      <email>Mbalenhle.Mbuyisa@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS</name>
      <address>
        <city>Mbeya</city>
        <country>Tanzania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>255-25-2503364</phone>
      <email>nelias@nimr-mmrc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>255-25-2503364</phone>
      <email>lmaganga@nimr-mmrc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Matero Reference Clinic CRS</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>260-95-0693971</phone>
      <email>roma.chilengi@cidrz.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>260-966848889</phone>
      <email>bupe.sichalwe@cidrz.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Zambia Emory HIV Research Project - Lusaka CoVPN CRS</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>260-96-6862787</phone>
      <email>wkilembe@rzhrg-mail.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>260-96-6862037</phone>
      <email>tsharkey@rzhrg-mail.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Zambia Emory HIV Research Project - Ndola CoVPN CRS</name>
      <address>
        <city>Ndola</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>260-96-6780601</phone>
      <email>minambao@rzhrg-mail.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>260-96-6862037</phone>
      <email>tsharkey@rzhrg-mail.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St Mary's CRS</name>
      <address>
        <city>Chitungwiza</city>
        <country>Zimbabwe</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>263-712-401199</phone>
      <email>tchipato@uzchs-ctrc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>263-772-288160</phone>
      <email>smaonera@uzchs-ctrc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Milton Park CRS</name>
      <address>
        <city>Harare</city>
        <country>Zimbabwe</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>263-772-511104</phone>
      <email>jhakim@mweb.co.zw</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>263-24-2701356</phone>
      <email>rmahachi@uzchs-ctrc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Seke South CRS</name>
      <address>
        <city>Harare</city>
        <country>Zimbabwe</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>263-774-430144</phone>
      <email>phunidzarira@uzchs-ctrc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>263-77-2460038</phone>
      <email>tchirenda@uzchs-ctrc.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Botswana</country>
    <country>Brazil</country>
    <country>Kenya</country>
    <country>Malawi</country>
    <country>Mexico</country>
    <country>Mozambique</country>
    <country>Peru</country>
    <country>South Africa</country>
    <country>Tanzania</country>
    <country>United States</country>
    <country>Zambia</country>
    <country>Zimbabwe</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 9, 2020</study_first_submitted>
  <study_first_submitted_qc>June 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2020</study_first_posted>
  <last_update_submitted>September 25, 2020</last_update_submitted>
  <last_update_submitted_qc>September 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

